; or (B) are community-based organizations. (4) Report An entity that receives a grant under paragraph (1) shall submit to the Secretary, at a time specified by the Secretary, a report describing each activity carried out pursuant to such paragraph and evaluating the effectiveness of such activity in raising awareness for liver cancer and other liver diseases. (5) Authorization of appropriations For purposes of carrying out this subsection, there is authorized to be appropriated $10,000,000 for each of fiscal years 2019 through 2023. Any amounts appropriated under this paragraph shall remain available until expended and shall be used to supplement and not supplant other Federal funds provided for activities under this subsection. . 5. Hepatitis B research Subpart 3 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 285c et seq.) is amended by adding at the end the following new section: 434B. Hepatitis B The Director of the Institute shall, in collaboration with the Director of the National Institute of Allergy and Infectious Diseases, issue targeted calls for hepatitis B research proposals focused on key research questions identified by the research community and discussed in peer-reviewed research journal articles. . 6. Changes relating to National Institute of Diabetes and Digestive and Kidney Diseases (a) Change of name of National Institute of Diabetes and Digestive and Kidney Diseases (1) In general Subpart 3 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 285c et seq.) is amended in the subpart heading by striking National Institute of Diabetes and Digestive and Kidney Diseases and inserting National Institute of Diabetes and Digestive, Kidney, and Liver Diseases . (2) Treatment of Director of National Institute of Diabetes and Digestive and Kidney Diseases The individual serving as the Director of the National Institute of Diabetes and Digestive and Kidney Diseases as of the date of enactment of this Act may continue to serve as the Director of the National Institute of